Strengths

● The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.18 for the 2022 fiscal year.

● Over the past four months, analysts' average price target has been revised upwards significantly.


Weaknesses

● As estimated by analysts, this group is among those businesses with the lowest growth prospects.

● As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.

● Low profitability weakens the company.

● The company benefits from high valuations in earnings multiples.

● The company is not the most generous with respect to shareholders' compensation.

● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.

● For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.

● The overall consensus opinion of analysts has deteriorated sharply over the past four months.